NCOIL Pushes Back Against Trump’s AI Regulation Order: What It Means for Insurance Professionals

Ai regulation governance image

A sharp political and regulatory conflict has erupted as the National Council of Insurance Legislators (NCOIL) publicly challenges President Donald Trump’s executive order on artificial intelligence. The directive seeks to reduce state involvement in AI oversight—an approach NCOIL argues threatens the very structure of U.S. insurance governance.

In a strongly worded December 15 statement, NCOIL expressed that it was “greatly disturbed” by the attempt to centralize AI authority in Washington, suggesting it could weaken consumer protection and restrict states’ ability to maintain regulatory balance. Their stance is unmistakable: states must preserve the right to craft their own policy, especially in a period of political gridlock.

Why This Matters: The Longstanding State vs. Federal Tug‑of‑War

Insurance regulation has traditionally belonged to the states. Moving that authority to the federal level could disrupt markets, slow innovation, and complicate compliance. This isn’t the first time such concerns have surfaced—a decade‑long moratorium on state AI regulation was previously shot down by federal lawmakers following pushback from NCOIL and major insurance trade groups warning the moratorium would “wrongly curtail” state authority.

“This moment is precisely the kind of opportunity in which the states should continue serving as the laboratories of democracy,” NCOIL declared—adding that Trump’s order will likely face significant legal challenges.

What the Executive Order Actually Says

The administration argues that inconsistent state‑level AI laws create confusion, ideological inconsistencies, and barriers to national commerce. To counter this, a new federal task force will evaluate and challenge any state AI regulations that clash with the administration’s unified direction.

According to the order, maintaining global AI leadership requires a “minimally burdensome national policy framework.”

What This Means for Insurance Professionals

AI regulation directly shapes how insurance professionals perform their work—particularly those involved in underwriting, claims automation, data modeling, and fraud prevention. Key impacts include:

  • How companies calculate and communicate risk
  • What consumer‑transparency rules must be followed
  • How AI models must be tested, monitored, and audited
  • How innovation is balanced against legal compliance

As new regulations emerge, staying educated is no longer optional—it’s a professional advantage and a compliance necessity.

Related Source & Further Reading

Original coverage from Insurance Journal:
State Insurance Legislators ‘Greatly Disturbed’ by Trump AI Regulation Order

Additional related reporting:
Federal Lawmakers Reject AI Regulation Moratorium
Insurance Industry Rejects Proposed Moratorium on AI Regulation

Stay Ahead of Industry Regulation with Cameron Academy

Professionals across insurance, real estate, mortgage, finance, and medical fields rely on high‑quality education to stay compliant and competitive. Whether you’re expanding your license or launching a new career, Cameron Academy offers state‑approved, real‑world‑focused training built to keep you ahead of regulatory change—AI included.

Visit: CameronAcademy.com

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Precision Medicine Market: A Tailored Approach Revolutionizing Healthcare

With increasing governmental and private investments, the demand for precision medicine is expected to rise steadily. The commitment to addressing chronic conditions, coupled with strategic industry collaborations and advanced diagnostic tools, will sustain market growth.

U.S. Wearable Medical Devices Market: Growth Trends and Future Prospects

The U.S. wearable medical devices market, currently valued at an estimated $11.45 billion in 2023, is set to experience an astronomical rise to approximately $112.67 billion by 2033.

By |December 3, 2024|Categories: Article, Healthcare, Technology|Tags: |0 Comments

The Future of Real Estate Market: What Lies Ahead?

The real estate market is on the brink of transformation, captivating the attention of buyers, sellers, investors, and industry professionals. As we look toward the end of 2024, experts predict a shift in the landscape, particularly with home prices expected to decline due to increased inventory levels.

By |December 3, 2024|Categories: Article, Market Trends, Real Estate|Tags: , |0 Comments

Bridging the Healthcare Gap in Rural Areas with Telehealth

According to the World Health Organization (WHO), nearly two billion people in rural and remote areas worldwide lack access to essential healthcare solutions. This staggering statistic highlights a critical issue: the digital divide that limits telehealth services, primarily due to inadequate broadband access.

By |December 2, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Navigating Ethical Challenges: AI in Healthcare

As AI becomes a staple in medical practice, it carries the risk of reinforcing existing biases entrenched in historical data. These biases can lead to skewed outcomes, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic groups.

By |December 2, 2024|Categories: Article, Ethics, Healthcare|Tags: , |0 Comments

New SCLC Biomarkers Enable Advances in Precision Medicine Approaches

A groundbreaking study published in Volume 15 of Oncotarget on October 11, 2024, titled 'Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC' showcases pivotal advancements in the fight against small cell lung cancer (SCLC).

By |December 2, 2024|Categories: Article, Cancer Treatment, Medical Research|Tags: , |0 Comments